{"DataElement":{"publicId":"7544341","version":"1","preferredName":"Concomitant Medication Domain Concomitant Medication Category Prior Therapy Administered Type","preferredDefinition":"Information that identifies the treatment/s previously given to a patient for cancer prior to enrollment.","longName":"CM_CMTRT_PRIORTX","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6400384","version":"1","preferredName":"Concomitant Medication Domain Concomitant Medication Category","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._A classification of concomitant medication data.","longName":"4550855v1.0:6400382v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4550855","version":"1","preferredName":"Concomitant Medication Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","longName":"C49568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Domain","conceptCode":"C49568","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06047D53-A3ED-FF3E-E050-BB89AD430B5B","latestVersionIndicator":"Yes","beginDate":"2014-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-22","modifiedBy":"ONEDATA","dateModified":"2014-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6400382","version":"1","preferredName":"Concomitant Medication Category","preferredDefinition":"A classification of concomitant medication data.","longName":"C83218","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Category","conceptCode":"C83218","definition":"A classification of concomitant medication data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7369ABB9-B62E-44AD-E053-F662850A110C","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7369ABB9-B63F-44AD-E053-F662850A110C","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"KUMMEROA","dateModified":"2021-06-09","changeDescription":"Elevated to Standard per governance approval by RA. 2021-6-9 ak. 1/4/19 tmt released/usage. created for CDASH 8/14/18 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7144269","version":"1","preferredName":"Prior Therapy Administered Type","preferredDefinition":"list of treatments previously given to a patient for cancer.","longName":"PRIOR_TX_ADM_TP","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Rapalogs","valueDescription":"Sirolimus","ValueMeaning":{"publicId":"5127411","version":"1","preferredName":"Sirolimus","longName":"5127411","preferredDefinition":"A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamune blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamune was previously called rapamycin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sirolimus","conceptCode":"C1212","definition":"A natural macrocyclic lactone produced by the bacterium Streptomyces hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target Of Rapamycin (mTOR), a key regulatory kinase. This results in inhibition of T lymphocyte activation and proliferation that occurs in response to antigenic and cytokine (IL-2, IL-4, and IL-15) stimulation and inhibition of antibody production. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C5DDD88-FA4E-F93D-E050-BB89AD437D4E","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9BCF-2868-E053-F662850AB340","beginDate":"2020-01-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Small Molecule Tryosine Kinase inhibitors","valueDescription":"Small Molecule Tyrosine Kinase Inhibitor","ValueMeaning":{"publicId":"7144270","version":"1","preferredName":"Small Molecule Tyrosine Kinase Inhibitor","longName":"7144270","preferredDefinition":"Limited in number, quantity, magnitude or extent.: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.: Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small","conceptCode":"C25376","definition":"Limited in number, quantity, magnitude or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Molecule","conceptCode":"C63816","definition":"An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tyrosine Kinase Inhibitor","conceptCode":"C1967","definition":"Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C5B6DE2-9BDD-2868-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2020-01-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9BF6-2868-E053-F662850AB340","beginDate":"2020-01-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Anti-retroviral therapy","valueDescription":"Agents administered to control the replication and/or spread of viruses","ValueMeaning":{"publicId":"2567116","version":"1","preferredName":"Agents administered to control the replication and/or spread of viruses","longName":"2567116","preferredDefinition":"Agents administered to control the replication and/or spread of viruses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D339-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C00-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Antisense","valueDescription":"Treatment with an agent that prevents or impairs the translation of the genetic message for production of a specific protein","ValueMeaning":{"publicId":"2567117","version":"1","preferredName":"Treatment with an agent that prevents or impairs the translation of the genetic message for production of a specific protein","longName":"2567117","preferredDefinition":"Treatment with an agent that prevents or impairs the translation of the genetic message for production of a specific protein","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D33A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C0A-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Bone marrow transplant","valueDescription":"High dose chemotherapy combined with transplantation of bone marrow cells","ValueMeaning":{"publicId":"2567119","version":"1","preferredName":"High dose chemotherapy combined with transplantation of bone marrow cells","longName":"2567119","preferredDefinition":"Bone marrow transplant NOS (MedDRA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D33C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C14-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Chemotherapy (NOS)","valueDescription":"Non-systemic chemotherapy treatment or chemotherapy not described by Chemotherapy Single Agent Systemic or Multi-Agent Systemic","ValueMeaning":{"publicId":"2567118","version":"1","preferredName":"Non-systemic chemotherapy treatment or chemotherapy not described by Chemotherapy Single Agent Systemic or Multi-Agent Systemic","longName":"2567118","preferredDefinition":"Non-systemic chemotherapy treatment or chemotherapy not described by Chemotherapy Single Agent Systemic or Multi-Agent Systemic","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D33B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"KUMMEROA","dateModified":"2022-09-12","changeDescription":null,"administrativeNotes":"2022.9.12 Added VM Alt Name for ticket request CADSR0001508. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C1F-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Chemotherapy multiple agents systemic","valueDescription":"Systemic chemotherapy with a regimen containing multiple agents","ValueMeaning":{"publicId":"2567120","version":"1","preferredName":"Systemic chemotherapy with a regimen containing multiple agents","longName":"2567120","preferredDefinition":"Systemic chemotherapy with a regimen containing multiple agents","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D33D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C29-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Chemotherapy non-cytotoxic","valueDescription":"Prior therapy with agents that are not known to cause damage to cycling cells","ValueMeaning":{"publicId":"2567122","version":"1","preferredName":"Prior therapy with agents that are not known to cause damage to cycling cells","longName":"2567122","preferredDefinition":"Prior therapy with agents that are not known to cause damage to cycling cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D33F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C33-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Chemotherapy single agent systemic","valueDescription":"Systemic chemotherapy with a single agent regimen","ValueMeaning":{"publicId":"2567123","version":"1","preferredName":"Systemic chemotherapy with a single agent regimen","longName":"2567123","preferredDefinition":"Systemic chemotherapy with a single agent regimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D340-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C3D-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Drug and/or Immunotherapy","valueDescription":"Drug and/or Immunotherapy","ValueMeaning":{"publicId":"2573552","version":"1","preferredName":"Drug and/or Immunotherapy","longName":"2573552","preferredDefinition":"Originally, therapeutic administration of serum or gamma globulin containing preformed antibodies produced by another individual; currently, immunotherapy includes nonspecific systemic stimulation, adjuvants, active specific immunotherapy, and adoptive immunotherapy.  New forms of immunotherapy include the use of monoclonal antibodies.  This approach has been widely adopted by cancer specialists, often in cases which fail to respond to other treatment.  Immunotherapy aims to boost immune system function, as with the administration of interferons and interleukin-2, or to attack cancerous cells directly, as with the injection of monoclonal antibodies.  Various immunotherapeutic techniques have also been employed among AIDS patients.  In addition, a number of alternative medical practices are claimed to enhance immune function, and various over-the-counter substances (e.g., goldenseal, lysine have gained popularity for this supposed property.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior Immunotherapy","conceptCode":"C16168","definition":"Originally, therapeutic administration of serum or gamma globulin containing preformed antibodies produced by another individual; currently, immunotherapy includes nonspecific systemic stimulation, adjuvants, active specific immunotherapy, and adoptive immunotherapy.  New forms of immunotherapy include the use of monoclonal antibodies.  This approach has been widely adopted by cancer specialists, often in cases which fail to respond to other treatment.  Immunotherapy aims to boost immune system function, as with the administration of interferons and interleukin-2, or to attack cancerous cells directly, as with the injection of monoclonal antibodies.  Various immunotherapeutic techniques have also been employed among AIDS patients.  In addition, a number of alternative medical practices are claimed to enhance immune function, and various over-the-counter substances (e.g., goldenseal, lysine have gained popularity for this supposed property.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC5D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"PWEST","dateCreated":"2005-03-15","modifiedBy":"REEVESD","dateModified":"2014-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C49-2868-E053-F662850AB340","beginDate":"2005-03-15","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Gene transfer","valueDescription":"Treatment of human disease by gene transfer","ValueMeaning":{"publicId":"2567124","version":"1","preferredName":"Treatment of human disease by gene transfer","longName":"2567124","preferredDefinition":"Treatment of human disease by gene transfer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D341-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C53-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Hematopoietic Stem Cell Transplantation","valueDescription":"Hematopoietic Stem Cell Transplantation","ValueMeaning":{"publicId":"2573553","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation","longName":"2573553","preferredDefinition":"A procedure to replace diseased or pathologic bone marrow with transplanted healthy bone marrow stem cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow Stem Cell Transplantation","conceptCode":"C25437","definition":"A procedure to replace diseased or pathologic bone marrow with transplanted healthy bone marrow stem cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"PWEST","dateCreated":"2005-03-15","modifiedBy":"REEVESD","dateModified":"2014-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C5D-2868-E053-F662850AB340","beginDate":"2005-03-15","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Hormonal therapy","valueDescription":"Cancer therapy which incorporates hormonal manipulation","ValueMeaning":{"publicId":"2567125","version":"1","preferredName":"Cancer therapy which incorporates hormonal manipulation","longName":"2567125","preferredDefinition":"Steroid therapy NOS (MedDRA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D342-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C67-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Image Directed Local Therapy","valueDescription":"Image Directed Local Therapy","ValueMeaning":{"publicId":"2573554","version":"1","preferredName":"Image Directed Local Therapy","longName":"2573554","preferredDefinition":"Image Directed Local Therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC5F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"PWEST","dateCreated":"2005-03-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C71-2868-E053-F662850AB340","beginDate":"2005-03-15","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Oncolytic virotherapy","valueDescription":"Anticancer treatment with a live, replication-competent virus","ValueMeaning":{"publicId":"2567128","version":"1","preferredName":"Anticancer treatment with a live, replication-competent virus","longName":"2567128","preferredDefinition":"Anticancer treatment with a live, replication-competent virus","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D345-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C7B-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Prior therapy NOS","valueDescription":"Prior Therapy (NOS)","ValueMeaning":{"publicId":"2561727","version":"1","preferredName":"Prior Therapy (NOS)","longName":"2561727","preferredDefinition":"An indicator that a person has been previously treated for the same condition or with the same therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior Therapy","conceptCode":"C16124","definition":"Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE2C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"REEVESD","dateModified":"2014-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C85-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Radiation therapy","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"2567129","version":"1","preferredName":"Radiation Therapy","longName":"2567129","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D346-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C8F-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Surgery","valueDescription":"Surgical procedure","ValueMeaning":{"publicId":"2567130","version":"1","preferredName":"Surgical procedure","longName":"2567130","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D347-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"REEVESD","dateModified":"2012-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9C99-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Therapeutic Device","valueDescription":"Therapeutic Medical Device","ValueMeaning":{"publicId":"4247832","version":"1","preferredName":"Therapeutic Medical Device","longName":"4247832","preferredDefinition":"Relating to or involved in therapy.: Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic","conceptCode":"C25277","definition":"Relating to or involved in therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medical Device","conceptCode":"C16830","definition":"Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F56EA6CC-AB75-81D4-E040-BB89AD4365B4","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9CA3-2868-E053-F662850AB340","beginDate":"2014-03-25","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Therapy (NOS)","valueDescription":"Therapy NOS","ValueMeaning":{"publicId":"2567131","version":"1","preferredName":"Therapy NOS","longName":"2567131","preferredDefinition":"Therapy NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D348-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9CAD-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Vaccine","valueDescription":"Substance or group of substances administered to induce the immune system to recognize and destroy tumors or microorganisms","ValueMeaning":{"publicId":"2567132","version":"1","preferredName":"Substance or group of substances administered to induce the immune system to recognize and destroy tumors or microorganisms","longName":"2567132","preferredDefinition":"Prophylaxis NOS (MedDRA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D349-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"KUMMEROA","dateModified":"2022-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C5B6DE2-9CB7-2868-E053-F662850AB340","beginDate":"2003-10-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"},{"value":"Steroids","valueDescription":"Steroid","ValueMeaning":{"publicId":"5511067","version":"1","preferredName":"Steroid","longName":"5511067v1.00","preferredDefinition":"The use of exogenous steroids for the treatment of any disease or disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Steroid Therapy","conceptCode":"C15370","definition":"The use of exogenous steroids for the treatment of any disease or disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EB2EF73-1A4A-33B0-E053-F662850AB0D7","latestVersionIndicator":"Yes","beginDate":"2016-10-12","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-10-12","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B81B6AB8-F9FA-493F-E053-4EBD850A53C9","beginDate":"2021-01-04","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","deletedIndicator":"No"},{"value":"Chemotherapy plus immunotherapy","valueDescription":"Immunotherapy Chemotherapy","ValueMeaning":{"publicId":"7544631","version":"1","preferredName":"Immunotherapy Chemotherapy","longName":"7544631","preferredDefinition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B81C3D8E-D420-5040-E053-4EBD850AC071","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B81C3D8E-D43B-5040-E053-4EBD850AC071","beginDate":"2021-01-04","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B7CBBB30-726C-49B5-E053-4EBD850ADD42","beginDate":"2020-12-31","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-31","modifiedBy":"ONEDATA","dateModified":"2020-12-31","deletedIndicator":"No"},{"value":"Cellular Therapy","valueDescription":"Cell Other Immunotherapy Cell Other Immunotherapy","ValueMeaning":{"publicId":"7412932","version":"1","preferredName":"Cell Other Immunotherapy Cell Other Immunotherapy","longName":"7412932","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.: Different than the one(s) previously specified or mentioned.: Therapy designed to induce changes in a patient's immune status in order to treat disease.: The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.: Different than the one(s) previously specified or mentioned.: Therapy designed to induce changes in a patient's immune status in order to treat disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE84262D-E8EB-3AD6-E053-4EBD850AC0A5","latestVersionIndicator":"Yes","beginDate":"2020-09-04","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-04","modifiedBy":"ONEDATA","dateModified":"2020-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCFCA319-C3AD-1C95-E053-4EBD850A200D","beginDate":"2022-04-19","endDate":null,"createdBy":"GALITG","dateCreated":"2022-04-19","modifiedBy":"ONEDATA","dateModified":"2022-04-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C5B6DE2-9BAB-2868-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2020-01-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2020-01-17","modifiedBy":"GALITG","dateModified":"2022-04-19","changeDescription":"Removed non-CDUS values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which treatment did patient r","type":"Preferred Question Text","description":"Which treatment did patient receive prior to enrollment?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B817AAAE-C3EB-578C-E053-4EBD850AA479","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-04","modifiedBy":"GALITG","dateModified":"2021-01-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}